Patents by Inventor Yaara Oppenheimer-Shaanan

Yaara Oppenheimer-Shaanan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING HYDROXYCINNAMIC ACID AND RELATED CONJUGATES, ANALOGUES AND DERIVATIVES, AND METHODS OF USE THEREOF
    Publication number: 20210144999
    Abstract: The present invention provides anti-microbial compositions comprising a hydroxycinnamic acid and related conjugates, analogues and derivatives, and methods of use thereof for enhancing production of anti-microbial agents in bacteria as well as for protecting plants from microbial infection.
    Type: Application
    Filed: July 9, 2018
    Publication date: May 20, 2021
    Applicants: YEDA RESEARCH AND DEVELOPMENT CO. LTD., THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD.
    Inventors: Ilana KOLODKIN-GAL, Yaara OPPENHEIMER-SHAANAN, Ariel OGRAN-NACHMAN, Michael MEIJLER, Eliane Hadas YARDENI
  • Compounds for treating bacterial infections
    Patent number: 9133231
    Abstract: Rel proteins as a novel therapeutic agent for treating bacterial threats. More specifically, a novel class of compounds of Formula (I) as disclosed herein which possess antibacterial activity and which inhibit RelA, RelSeq or RelSpo synthetic activity or bacterial spore formation. Also, pharmaceutical compositions of such compounds and a method of combating bacteria, or treating bacterial infections, by administering to a subject in need thereof such compounds or pharmaceutical compositions.
    Type: Grant
    Filed: August 3, 2011
    Date of Patent: September 15, 2015
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Ezequiel Wexselblatt, Joshua Katzhendler, Ilana Kaspy, Gad Glaser, Roee Vidavski, Hafiz Mawasi, Sigal Ben Yehuda, Yaara Oppenheimer-Shaanan
  • COMPOUNDS FOR TREATING BACTERIAL INFECTIONS
    Publication number: 20130203694
    Abstract: Rel proteins as a novel therapeutic agent for treating bacterial threats. More specifically, a novel class of compounds of Formula (I) as disclosed herein which possess anti-bacterial activity and which inhibit RelA, RelSeq or RelSpo synthetic activity or bacterial spore formation. Also, pharmaceutical compositions of such compounds and a method of combating bacteria, or treating bacterial infections, by administering to a subject in need thereof such compounds or pharmaceutical compositions.
    Type: Application
    Filed: August 3, 2011
    Publication date: August 8, 2013
    Applicant: YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
    Inventors: Ezequiel Wexselblatt, Joshua Katzhendler, Gad Glaser, Sigal Ben Yehuda, Roee Vidavski, Hafiz Mawasi, Ilana Kaspy, Yaara Oppenheimer-Shaanan